Following last week's meeting of the Technology Appraisal Advisory Committee for the appraisal of fingolimod (Gilenya), a new disease modifying drug for relapsing remitting MS, NICE (National Institute for Health and Clinical Excellence) has announced the following timelines:
If an Appraisal Consultation Document (ACD) is issued, it will be released during the week commencing Monday 25 July.
If a Final Appraisal Determination (FAD) is issued, it will be released during the week commencing Monday 8 August.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309